According to a new study from the National Institutes of Health ( NIH ), medications for attention deficit hyperactive disorder (ADHD) do not appear to cause genetic damage.

The health of a baby in the first five minutes of exiting the womb may be associated with his or her risk of developing attention-deficit hyperactivity disorder (ADHD).